Literature DB >> 8293181

Polyomavirus models of brain infection and the pathogenesis of multiple sclerosis.

G L Stoner1.   

Abstract

Multiple sclerosis (MS) is generally considered to be an autoimmune disorder with myelin as the target and with several unidentified viruses playing ancillary roles, possibly through molecular mimicry. Although this paradigm has led to important progress on potential mechanisms of myelin loss, neither a target antigen in myelin nor a triggering mechanism has yet been identified, leaving the etiology of MS still unknown. Animal models of viral demyelination and studies showing that JC virus (JCV), the polyomavirus which causes progressive multifocal leukoencephalopathy (PML), may be latent in some normal human brains suggest another possibility. A host immune response targeting proteins expressed at low levels from viral DNA latent in the central nervous system (CNS) might underlie a focal demyelinating disease such as MS. A shift from autoimmunity to a latent-virus model is not a trivial substitution of target antigens. This shift would expand the search for a definitive laboratory test for MS and could lead to improved therapeutic and preventive approaches.

Entities:  

Mesh:

Year:  1993        PMID: 8293181      PMCID: PMC7161790          DOI: 10.1111/j.1750-3639.1993.tb00748.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  145 in total

1.  MS-like leukoencephalopathy in HIV-1.

Authors:  B J Brew
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

Review 2.  Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus.

Authors:  M Rodriguez; E Oleszak; J Leibowitz
Journal:  Crit Rev Immunol       Date:  1987       Impact factor: 2.214

3.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

Review 4.  Lessons from magnetic resonance imaging in multiple sclerosis.

Authors:  W I McDonald; D Barnes
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

5.  HLA-DP beta and susceptibility to multiple sclerosis: an analysis of caucasoid and Japanese patient populations.

Authors:  A B Begovich; R C Helmuth; J R Oksenberg; K Sakai; T Tabira; T Sasazuki; L Steinman; H A Erlich
Journal:  Hum Immunol       Date:  1990-08       Impact factor: 2.850

6.  Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.

Authors:  M Chowdhury; J P Taylor; H Tada; J Rappaport; F Wong-Staal; S Amini; K Khalili
Journal:  Oncogene       Date:  1990-12       Impact factor: 9.867

7.  Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes.

Authors:  A Marcuzzi; J Weinberger; O K Weinberger
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

8.  Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences.

Authors:  G S Ault; G L Stoner
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

9.  Fulminating multiple sclerosis-like leukoencephalopathy revealing human immunodeficiency virus infection.

Authors:  F Gray; L Chimelli; M Mohr; P Clavelou; F Scaravilli; J Poirier
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

Review 10.  Immunology of multiple sclerosis.

Authors:  H F McFarland
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

View more
  4 in total

1.  A case of oligodendroglioma and multiple sclerosis: Occam's razor or Hickam's dictum?

Authors:  Afsaneh Shirani; Gregory F Wu; Caterina Giannini; Anne H Cross
Journal:  BMJ Case Rep       Date:  2018-06-28

2.  Differential expression of mRNAs for JC virus large and small tumor antigens in brain tissues from progressive multifocal leukoencephalopathy patients with and without AIDS.

Authors:  M Ishaq; G L Stoner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 3.  Concurrence of multiple sclerosis and brain tumors.

Authors:  Domenico Plantone; Rosaria Renna; Emilia Sbardella; Tatiana Koudriavtseva
Journal:  Front Neurol       Date:  2015-03-04       Impact factor: 4.003

Review 4.  Transient virus infection and multiple sclerosis.

Authors:  G J Atkins; S McQuaid; M M Morris-Downes; S E Galbraith; S Amor; S L Cosby; B J Sheahan
Journal:  Rev Med Virol       Date:  2000 Sep-Oct       Impact factor: 6.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.